Cardlytics Balance Sheet Health
Financial Health criteria checks 3/6
Cardlytics has a total shareholder equity of $210.0M and total debt of $212.9M, which brings its debt-to-equity ratio to 101.4%. Its total assets and total liabilities are $534.4M and $324.3M respectively.
Key information
101.4%
Debt to equity ratio
US$212.89m
Debt
| Interest coverage ratio | n/a |
| Cash | US$71.25m |
| Equity | US$210.03m |
| Total liabilities | US$324.34m |
| Total assets | US$534.37m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CYX's short term assets ($185.3M) exceed its short term liabilities ($104.6M).
Long Term Liabilities: CYX's short term assets ($185.3M) do not cover its long term liabilities ($219.7M).
Debt to Equity History and Analysis
Debt Level: CYX's net debt to equity ratio (67.4%) is considered high.
Reducing Debt: CYX's debt to equity ratio has increased from 78.8% to 101.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CYX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CYX has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 13.7% each year